Molina Healthcare, Inc. (NYSE:MOH) Position Decreased by Capital Research Global Investors

Capital Research Global Investors lowered its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 0.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,486,558 shares of the company's stock after selling 4,189 shares during the period. Capital Research Global Investors owned approximately 6.10% of Molina Healthcare worth $1,014,757,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Wellington Management Group LLP lifted its stake in shares of Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after purchasing an additional 181,073 shares in the last quarter. FMR LLC lifted its position in shares of Molina Healthcare by 31.1% during the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after purchasing an additional 427,276 shares in the last quarter. Geode Capital Management LLC grew its holdings in Molina Healthcare by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after purchasing an additional 34,992 shares in the last quarter. Invesco Ltd. increased its stake in Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after buying an additional 294,180 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in Molina Healthcare by 15.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock valued at $200,307,000 after buying an additional 91,229 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Insiders Place Their Bets

In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the transaction, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.10% of the stock is owned by insiders.

Molina Healthcare Stock Performance

MOH traded down $18.45 during trading hours on Thursday, hitting $313.55. The company's stock had a trading volume of 1,062,343 shares, compared to its average volume of 670,498. The company has a 50-day simple moving average of $317.63 and a 200 day simple moving average of $307.82. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $17.15 billion, a PE ratio of 15.34, a PEG ratio of 1.06 and a beta of 0.70. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $370.99.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating analysts' consensus estimates of $5.86 by $0.22. The company had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. During the same period last year, the company earned $5.73 earnings per share. As a group, sell-side analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Wall Street Analyst Weigh In

MOH has been the topic of several recent analyst reports. Barclays cut their price target on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research note on Friday, February 7th. Stephens reaffirmed an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Robert W. Baird restated a "neutral" rating and issued a $375.00 target price (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Mizuho boosted their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Sanford C. Bernstein began coverage on shares of Molina Healthcare in a research note on Tuesday. They set an "outperform" rating and a $414.00 target price for the company. Nine analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and an average target price of $363.62.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.